Regulation of angiogenesis by Eph-Ephrin interactions

被引:212
作者
Kuijper, Sanne [1 ]
Turner, Christopher J. [1 ]
Adams, Ralf H. [1 ]
机构
[1] London Res Inst, Vasc Dev Lab, Canc Res UK, London, England
关键词
D O I
10.1016/j.tcm.2007.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The large families of Eph receptor tyrosine kinases and their ephrin ligands transduce signals in a cell-cell contact-dependent fashion and thereby coordinate the growth, differentiation, and patterning of almost every organ and tissue. Eph-ephrin interactions can trigger a wide array of cellular responses, including cell adhesion, boundary, formation, and repulsion. The exact mechanisms leading to this diversity of responses are unclear but appear to involve differential signaling, proteolytic cleavage of ephrins, and endocytosis of the ligand-receptor complex. In the developing cardiovascular system, Eph and ephrin molecules control the angiogenic remodeling of blood vessels and lymphatic vessels and play essential roles in endothelial cells as well as in supporting pericytes and vascular smooth muscle cells. Recent evidence suggests that Ephs and ephrins may also be involved in pathological angiogenesis, in particular; the neovascularization of tumors. Consequently, the expression, interactions, or signaling of Eph-ephrin molecules might be targets for future therapeutic approaches.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 55 条
[1]   Angiogenesis and ophthalmic disease [J].
Adamis A.P. ;
Aiello L.P. ;
D'Amato R.A. .
Angiogenesis, 1999, 3 (1) :9-14
[2]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[3]   Endothelial/pericyte interactions [J].
Armulik, A ;
Abramsson, A ;
Betsholtz, C .
CIRCULATION RESEARCH, 2005, 97 (06) :512-523
[4]   EphB receptor activity suppresses colorectal cancer progression [J].
Batlle, E ;
Bacani, J ;
Begthel, H ;
Jonkeer, S ;
Gregorieff, A ;
van de Born, M ;
Malats, N ;
Sancho, E ;
Boon, E ;
Pawson, T ;
Gallinger, S ;
Pals, S ;
Clevers, H .
NATURE, 2005, 435 (7045) :1126-1130
[5]  
BERTSHOLTZ C, 2005, EXS, P115
[6]   A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis [J].
Bin Fang, W ;
Brantley-Sieders, DM ;
Parker, MA ;
Reith, AD ;
Chen, J .
ONCOGENE, 2005, 24 (53) :7859-7868
[7]   EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation [J].
Brantley-Sieders, DM ;
Caughron, J ;
Hicks, D ;
Pozzi, A ;
Ruiz, JC ;
Chen, J .
JOURNAL OF CELL SCIENCE, 2004, 117 (10) :2037-2049
[8]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[9]   Silencing of EphA3 through a cis interaction with ephrinA5 [J].
Carvalho, RF ;
Beutler, M ;
Marler, KJM ;
Knöll, B ;
Becker-Barroso, E ;
Heintzmann, R ;
Ng, T ;
Drescher, U .
NATURE NEUROSCIENCE, 2006, 9 (03) :322-330
[10]   Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis [J].
Castellvi, Josep ;
Garcia, Angel ;
de la Torre, Javier ;
Hernandez, Javier ;
Gil, Antonio ;
Xercavins, Jordi ;
Ramon y Cajal, Santiago .
HUMAN PATHOLOGY, 2006, 37 (07) :883-889